1 Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles

2 National survey of susceptibility to antimicrobials amongst clinical isolates of Pseudomonas aeruginosa

3 Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001

4 Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different!

5 In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli

6 Intracellular activity of azithromycin against bacterial enteric pathogens

7 Community-based surveillance in the united states of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons

8 Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States

9 Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model

10 Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit

11 Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008)

12 Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women

13 Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005

14 Drug costs and bacterial susceptibility after implementing a single-fluoroquinolone use policy at a university hospital

15 In vitro and in vivo inhibition of ortho- and paramyxovirus infections by a new class of sulfonic acid polymers interacting with virus-cell binding and/or fusion

16 Antimicrobial resistance of diarrheagenic Escherichia coli isolated from children under the age of 5 years from Ifakara, Tanzania

17 Multi-resistant Pseudomonas aeruginosa outbreak associated with contaminated tap water in a neurosurgery intensive care unit

18 Voriconazole: a new triazole antifungal agent

19 Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999

20 Comparison of activities of broad-spectrum beta-lactam compounds against 1,128 gram-positive cocci recently isolated in cancer treatment centers

21 Factors influencing fluoroquinolone resistance

22 Application of fluoroquinolone pharmacodynamics

23 Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997

24 Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network

25 Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland

26 Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia

27 Susceptibilities of Yersinia pestis strains to 12 antimicrobial agents

28 Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens

29 Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men

30 Microbiological findings in febrile neutropenia

31 Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease

32 Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection

33 Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005

34 In vitro activity of ertapenem against bacterial isolates from cancer patients

35 Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children

36 Inappropriate antibiotic use in soft tissue infections

37 Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus

38 Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936)

39 Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis

40 Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States

41 Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study

42 Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone

43 Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997)

44 Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco

45 Present and future therapeutic strategies for melioidosis and glanders

46 Linezolid activity compared to those of selected macrolides and other agents against aerobic and anaerobic pathogens isolated from soft tissue bite infections in humans

47 Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance

48 Investigation into the selection frequency of resistant mutants and the bacterial kill rate by levofloxacin and ciprofloxacin in non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients

49 Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure

50 Methicillin-resistant S. aureus infections among patients in the emergency department

51 Two-year assessment of the pathogen frequency and antimicrobial resistance patterns among organisms isolated from skin and soft tissue infections in Latin American hospitals: results from the SENTRY antimicrobial surveillance program, 1997-98. SENTRY Study Group

52 Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections

53 Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection

54 Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned

55 Pharmacodynamics of levofloxacin and ciprofloxacin in a murine pneumonia model: peak concentration/MIC versus area under the curve/MIC ratios

56 High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections

57 Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation

58 Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy

59 Antibiotic susceptibilities of human isolates of Pasteurella multocida

60 Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae

61 Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections

62 Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects, and therapy

63 Suboptimal aminoglycoside dosing in critically ill patients

64 Emergence of macrolide-resistant Streptococcus pyogenes strains in French children

65 A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group

66 Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide

67 Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain

68 In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis

69 A clinical profile of multidrug resistant typhoid fever

70 Impetigo. Current etiology and comparison of penicillin, erythromycin, and cephalexin therapies

71 Early-onset group B streptococcal disease in the era of maternal screening

72 Morphological changes induced by imipenem and meropenem at sub-inhibitory concentrations in Acinetobacter baumannii

73 [Epidemiology of fungemia in a university hospital; therapeutic incidence]

74 Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal

75 Fidaxomicin versus vancomycin for Clostridium difficile infection

76 The burden of invasive bacterial infections in Pemba, Zanzibar

77 Determinants of amikacin first peak concentration in critically ill patients

78 Invasive Gram-negative bacilli are frequently resistant to standard antibiotics for children admitted to hospital in Kilifi, Kenya

79 Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system

80 Lack of antimicrobial resistance in Yersinia pestis isolates from 17 countries in the Americas, Africa, and Asia

81 Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England

82 emm Types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: What has changed in 11 years?

83 Detection of CMY-2, CTX-M-14, and SHV-12 beta-lactamases in Escherichia coli fecal-sample isolates from healthy chickens

84 Group A Streptococci from carriage and disease in Portugal: evolution of antimicrobial resistance and T antigenic types during 2000-2002

85 Typhoid outbreak in Songkhla, Thailand 2009-2011: clinical outcomes, susceptibility patterns, and reliability of serology tests

86 Bacteremia in febrile Malawian children: clinical and microbiologic features

87 In vitro and in vivo activities of anti-influenza virus compound T-705

88 A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec

89 Multidrug-resistant Salmonella enterica, Democratic Republic of the Congo

90 Correlation of minimum inhibitory concentrations between human and animal antimicrobials against Escherichia coli isolated from livestock

91 Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA

92 Risk factors for nasopharyngeal carriage of resistant Streptococcus pneumoniae and detection of a multiply resistant clone among children living in the Yukon-Kuskokwim Delta region of Alaska

93 Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice

94 Observation of Saccharomyces cerevisiae in blood of patient undergoing root canal treatment

95 Conditional lethality of the diprotic weak bases chloroquine and quinacrine against Cryptococcus neoformans

96 Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada

97 Multidrug-resistant typhoid fever

Keyword Connections

Journals

Research Groups

Bibliographies